Am J Epidemiol 2003; 157:467-471.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City
1 Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY.
2 National Development and Research Institutes, Center for AIDS Research, New York, NY.
3 New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, NY.
4 Thailand–United States Collaboration, Centers for Disease Control and Prevention, Atlanta, GA.
Cohort studies of young (aged 18–30 years) injecting drug users recruited in 1997–1999 in the Harlem and Lower East Side areas of New York City, New York, were used to assess the incidence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). The authors found that HIV incidence was low at both sites: 0.8/100 person-years at the Harlem site and 0/100 person-years at the Lower East Side site. In contrast, HBV incidence was moderate (12.2/100 person-years) at the Harlem site and high (30.7/100 person-years) at the Lower East Side site. Similarly, HCV incidence was moderate (9.3/100 person-years) at the Harlem site and high (34.0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence.
cohort studies; hepatitis B virus; hepatitis C-like viruses; HIV; injections, intravenous; substance-related disorders
Abbreviations: Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Page-Shafer, B. L. Pappalardo, L. H. Tobler, B. H. Phelps, B. R. Edlin, A. R. Moss, T. L. Wright, D. J. Wright, T. R. O'Brien, S. Caglioti, et al. Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates J. Clin. Microbiol., February 1, 2008; 46(2): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Heimer, L. E. Grau, E. Curtin, K. Khoshnood, and M. Singer Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts Am J Public Health, January 1, 2007; 97(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Armstrong, A. Wasley, E. P. Simard, G. M. McQuillan, W. L. Kuhnert, and M. J. Alter The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 Ann Intern Med, May 16, 2006; 144(10): 705 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Des Jarlais, T. Perlis, K. Arasteh, L. V. Torian, S. Beatrice, J. Milliken, D. Mildvan, S. Yancovitz, and S. R. Friedman HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services Am J Public Health, August 1, 2005; 95(8): 1439 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C S Bradshaw, L I Pierce, S N Tabrizi, C K Fairley, and S M Garland Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling Sex Transm Inf, February 1, 2005; 81(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Frumkin Healthy Places: Exploring the Evidence Am J Public Health, September 1, 2003; 93(9): 1451 - 1456. [Abstract] [Full Text] [PDF]
|
|